2020-08-17 19:37 With years of research and development experience in antibody discovery, scientists of Creative Biolabs have developed the Native™ Antibody Discovery Platform to generate monoclonal antibody with native and in vivo characteristics. This proprietary platform takes advantage of the antigen-specific B lymphocytes cytometry technology, and can ideally generate large scale of candidate shark antibodies in one step. Moreover, these shark antibodies are all composed of native paired heavy-chains and light-chains (for IgM and IgW) or just heavy-chains (for IgNAR), and have already gone through the in vivo affinity maturation. Thus, our Native™ shark monoclonal antibody will possess higher specificity and affinity than those produced by other techniques and will be intrinsically more appropriate for the development of single domain antibody or other research objectives.